Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conservative Versus Surgical Treatment of Appendicitis
NCT00469430Phase 2Completed
- Sponsor
- University of Gothenburg
- Start
- May 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cefotaxime and metronidazole in appendicitis (2 arms), sponsored by University of Gothenburg. Primary endpoint: Treatment Efficacy at 1 year. Started May 2006; status: completed.
02
Drugs
cefotaximemetronidazole
03
Conditions
appendicitis
Beyond the preview
Go deeper on NCT00469430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00469430.